{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:41:20Z","timestamp":1782794480255,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1127538"],"award-info":[{"award-number":["GNT1127538"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1145303"],"award-info":[{"award-number":["GNT1145303"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009781","name":"Australian Centre for HIV and Hepatitis Virology Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jhep.2021.07.031","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T01:24:41Z","timestamp":1628385881000},"page":"34-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-5026","authenticated-orcid":false,"given":"Hui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Locarnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1490-0547","authenticated-orcid":false,"given":"Darren","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7273-9128","authenticated-orcid":false,"given":"Rachel","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Colledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2612-299X","authenticated-orcid":false,"given":"Sally","family":"Soppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2658-1846","authenticated-orcid":false,"given":"Thao","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2715-2541","authenticated-orcid":false,"given":"Peter A.","family":"Revill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Mark","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Wines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1586-9409","authenticated-orcid":false,"given":"Renae","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4252-086X","authenticated-orcid":false,"given":"Nadia","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2021.07.031_bib1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013","volume":"388","author":"Stanaway","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jhep.2021.07.031_bib2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.07.031_bib3","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.28025","article-title":"Present and future therapies of hepatitis B: from discovery to cure","volume":"62","author":"Liang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.07.031_bib4","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v13.i1.65","article-title":"Hepatitis B virus morphogenesis","volume":"13","author":"Bruss","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.07.031_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2017.05.017","article-title":"Hepatitis B surface antigen on subviral particles reduces the neutralizing effect of anti-HBs antibodies on hepatitis B viral particles in\u00a0vitro","volume":"509","author":"Rydell","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2021.07.031_bib6","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1172\/JCI116497","article-title":"The serology of chronic hepatitis B infection revisited","volume":"91","author":"Maruyama","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2021.07.031_bib7","first-page":"673","article-title":"Chronic liver disease: the detection and characterization of circulating immune complexes","volume":"49","author":"Brown","year":"1983","journal-title":"Immunology"},{"key":"10.1016\/j.jhep.2021.07.031_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3851\/IMP2707","article-title":"Experimental HBsAg\/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir","volume":"19","author":"De Niet","year":"2014","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2021.07.031_bib9","first-page":"493","article-title":"Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus","volume":"84","author":"Madalinski","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2021.07.031_bib10","first-page":"246","article-title":"Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers","volume":"43","author":"Anh-Tuan","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2021.07.031_bib11","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.07.031_bib12","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jhep.2014.08.033","article-title":"Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management","volume":"61","author":"Chang","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.07.031_bib13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/gast.2001.22461","article-title":"Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease","volume":"120","author":"Perrillo","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.07.031_bib14","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/liv.13716","article-title":"ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B","volume":"38","author":"Wong","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.07.031_bib15","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/liv.14207","article-title":"Predicting HBsAg clearance in genotype A chronic hepatitis B using HBsAg epitope profiling: a biomarker for functional cure","volume":"39","author":"Walsh","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.07.031_bib16","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2021.07.031_bib17","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4049\/jimmunol.1502551","article-title":"Dimeric Fc\u03b3R ectodomains as probes of the Fc receptor function of anti-influenza virus IgG","volume":"197","author":"Wines","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2021.07.031_bib18","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.15252\/emmm.201606593","article-title":"Immunoregulatory functions of immune complexes in vaccine and therapy","volume":"8","author":"Wen","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jhep.2021.07.031_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1126\/science.6231724","article-title":"Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen","volume":"224","author":"Celis","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.jhep.2021.07.031_bib20","doi-asserted-by":"crossref","first-page":"e2565","DOI":"10.1371\/journal.pone.0002565","article-title":"A\u00a0randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients","volume":"3","author":"Xu","year":"2008","journal-title":"PloS one"},{"key":"10.1016\/j.jhep.2021.07.031_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jhep.2013.05.003","article-title":"Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings","volume":"59","author":"Xu","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.07.031_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.20411\/pai.v3i1.228","article-title":"ADCC-mediated CD56(DIM) NK cell responses are associated with early HBsAg clearance in acute HBV infection","volume":"3","author":"Yu","year":"2018","journal-title":"Pathog Immun"},{"key":"10.1016\/j.jhep.2021.07.031_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0016-5085(87)90863-8","article-title":"Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic\/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis","volume":"92","author":"Chu","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.07.031_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jcp.48.5.470","article-title":"Membrane staining for hepatitis B surface antigen on hepatocytes: a sensitive and specific marker of active viral replication in hepatitis B","volume":"48","author":"Chu","year":"1995","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jhep.2021.07.031_bib25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.4049\/jimmunol.1602161","article-title":"Dimeric Fcgamma receptor enzyme-linked immunosorbent assay to study HIV-specific antibodies: a new look into breadth of Fcgamma receptor antibodies induced by the RV144 vaccine trial","volume":"199","author":"McLean","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2021.07.031_bib26","doi-asserted-by":"crossref","first-page":"100254","DOI":"10.1016\/j.xcrm.2021.100254","article-title":"Improved HIV-positive infant survival is correlated with high levels of HIV-specific ADCC activity in multiple cohorts","volume":"2","author":"Yaffe","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jhep.2021.07.031_bib27","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1128\/JVI.00285-16","article-title":"Antibody responses with Fc-mediated functions after vaccination of HIV-infected subjects with trivalent influenza vaccine","volume":"90","author":"Kristensen","year":"2016","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2021.07.031_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2020.01.066","article-title":"Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults","volume":"38","author":"Vanderven","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jhep.2021.07.031_bib29","first-page":"217","article-title":"Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers","author":"Hehle","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhep.2021.07.031_bib30","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1200\/JCO.2014.56.7081","article-title":"Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study","volume":"32","author":"Seto","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jhep.2021.07.031_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0033-1345722","article-title":"Immunosuppression and HBV reactivation","volume":"33","author":"Shouval","year":"2013","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2021.07.031_bib32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.07.031_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/imm.12554","article-title":"Ectopic lymphoid follicles: inducible centres for generating antigen-specific immune responses within tissues","volume":"147","author":"Jones","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.jhep.2021.07.031_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.510300107","article-title":"Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C","volume":"30","author":"Murakami","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.07.031_bib35","doi-asserted-by":"crossref","first-page":"8766","DOI":"10.1073\/pnas.1003854107","article-title":"B\u00a0cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure","volume":"107","author":"Farci","year":"2010","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821019590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821019590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:55:28Z","timestamp":1777510528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827821019590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0168827821019590"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.07.031","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver. All rights reserved.","name":"copyright","label":"Copyright"}]}}